Dev Kurdikar

“Since we announced the termination of our patch pump program five months ago, we have been advancing the next phase of Embecta’s transformation. At the heart of this transformation are three strategic priorities that are guiding our execution and shaping our future.”

“Since the spin, which occurred on April 1, 2022, our strategic priorities over the past two and a half years have been focused on three areas.”

“Let us start with Slide 5, where you will see the three strategic priorities that we’ve executed since our spin-off in April of 2022. First, we continue to strengthen our base business while maintaining our global leadership position in the category of insulin injection devices.”

“With the introduction of the first specialized insulin delivery device in 1924, this year marked the 100th year of our journey to deliver better diabetes care through innovation.”

“The completion of fiscal 2023 marks our first full fiscal year as a stand-alone company, a company that is dedicated to developing and providing solutions that make life better for people living with diabetes, and I could not be prouder of our teams around the world.”